OpenAI’s recent investment in a brain‑implant startup for cancer detection marks a new frontier where AI meets neurotechnology, highlighting both the promise and the ethical questions surrounding this emerging field.
Science Corp has implanted its vision‑restoring chip in the first Stargardt disease patient, marking a key advance for retinal therapy and brain‑computer interface research, as announced at TechCrunch Disrupt.